Clinical Trial Update: Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a reduced-toxicity myeloablative conditioning regimen for cord blood transplantation in pediatric patients with acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: The Korean Society of Pediatric Hematology Oncology | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN